Benzinga's Top Pre-Market Gainers
Amylin Pharmaceuticals Inc (NASDAQ: AMLN) surged 15.90% to $14.07 in the pre-market session. AMLN and Alkermes plc (NASDAQ: ALKS) reported that the US Food and Drug Administration has approved BYDUREON™.
GTx Inc (NASDAQ: GTXI) added 14.21% to $4.50 in the pre-market session. GTXI is scheduled to report its quarterly earnings on 23 February.
Partner Communications Company (NASDAQ: PTNR) moved up 4.20% to $7.93 in the pre-market session. PTNR has a dividend yield of 8.90%.
Star Scientific Inc (NASDAQ: CIGX) soared 2.47% to $2.90 in the pre-market trading. CIGX shares have surged 79.11% over the past 52 weeks, while the S&P 500 index has gained 2.35% in the same period.
© 2017 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.